U.S. Immunohematology Market - Databook 2025 to 2034

The U.S. immunohematology market size surpassed USD 853.1 million in 2024 and is predicted to reach around USD 1,143.1 million by 2034, registering a CAGR of 2.96% from 2025 to 2034.

Highlights of the U.S. Immunohematology Market

• By product, the reagents segment underwent notable growth in the U.S. immunohematology market during 2024.
• By product, the analyzers segment will gain a significant share of the market over the studied period of 2025 to 2034.
• By technology, the PCR segment enjoyed a prominent position in the U.S. immunohematology market during 2024.
• By technology, the microplates segment is predicted to witness significant growth in the market over the forecast period.
• By end-user, the diagnostics laboratories segment captured a significant portion of the U.S. immunohematology market in 2024.
• By end-user, the hospitals segment projected to expand rapidly in the market in the coming years.

Industry Valuation and Growth Rate Projection

Immunohematology is the branch of immunology that deals with the immunologic properties of blood. Immunology is the study of RBC antigens and antibodies associated with blood transfusions. There are more than 230 antigen types present on the surface of RBCs that based on their chemical structure, can be grouped into two major categories polypeptides and carbohydrates. The primary indication of immunohematological testing in prenatal patient is to detect and identify maternal red cell antibodies. The U.S. immunohematology market growth is driven by technological innovation in immunohematology, rise in number of blood donation awareness programs in developing countries, and rising prevalence rate of many hematological disorders.

The U.S. immunohematology market applications include if there are antibodies that are expected to haemolyze the foetus’ red cells, their strength of reactivity must be tested and foetus’ antigen status determined. In immunohematology, many tests are done including direct coombs test, cross match by tube and gel card method, Rh factor discrepancies, forward and reverse grouping, peripheral smear, complete blood count, and blood grouping and cross match.

Market Trends

• Increasing patch management solutions: Patch management solutions is important for closing security gaps, fixing software bugs, and preventing attackers from exploiting vulnerabilities. It is the practice of deploying driver, firmware, operation system (OS), and application updates to computing endpoints. Patch management is critical to keeping systems updated, reducing attack surfaces, and ensuring employee productivity. Applying latest patch management is the best way to avoid cyberattacks that look to take benefit of known security vulnerabilities. This can help to the growth of the U.S. immunohematology market.
• Government regulations: Immunohematology reference laboratories provide an exchange of information and consultation on rare blood group antibodies, grouping, component preparation, and therapy, blood compatibility and research. Government regulations can protect consumers and help businesses thrive at the same time. Government business regulation laws offer many benefits that can support business growth and stability. By establishing clear rules, these regulations help prevent unfair practices and monopolistic behaviour, allowing businesses to compete on a level playing field.

Restraints

• High costs of techniques: Cost of techniques is term used to describe the costs these are caused due to introducing new product platforms and products, and also managing the variety of products produced. As demand for particular techniques increases, the available supply decreases.
• Lack of skilled professionals: The potential repercussions include higher safety risks, rising employee costs, and spiralling worker morale. Skill shortage means a condition in which there is an inadequate supply of skilled professionals in specific industry or field, resulting in a deficit of qualified workers to fulfil the industry’s demands.

Opportunity

• Increasing investment in research and development: Through investing in research and development (R&D), we can develop an advantage over competitors and establish ourself as a leader in the market. The development of new products and services can also generate new intellectual property for business which can further benefit financially. The main benefit of investment research is to make well informed decisions based on financial data which will help the growth of the U.S. immunohematology market.

Recent Developments in the U.S. Immunohematology Market

• In June 2024, the new Yumizen H550 compact hematology analyser range offers combined testing for CBC/DIFF with ESR results from whole blood in 60 seconds was launched by Horiba.
• In December 2024, a joint software as a service solution in hematological malignancies for hematology clinical trial design, research analytics, and clinical trial operational optimization was announced by ConcertAI and NeoGenomics.